19 studies found for:    " December 12, 2006":" January 12, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" December 12, 2006":" January 12, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (19 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine LFn-p24 Administered by the Intramuscular (IM) Route in Healthy Adults
Condition: HIV Infections
Intervention: Biological: HIV LFn-p24
2 Terminated Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients
Condition: HIV Infection
Interventions: Drug: atazanavir;   Drug: lopinavir/ritonavir
3 Completed Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136
Condition: HIV Infections
Interventions: Drug: Darunavir;   Drug: ritonavir
4 Withdrawn Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African Adults
Condition: HIV Infections
Interventions: Biological: VRC-HIVDNA016-00-VP;   Biological: VRC-HIVADV014-00-VP;   Biological: Vaccine placebo
5 Completed Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African Adults
Condition: HIV Infections
Interventions: Biological: MRKAd5 HIV-1 gag/pol/nef;   Other: Placebo
6 Recruiting Oral Human Papillomavirus Infection in HIV-infected Men
Conditions: Papillomavirus Infections;   HIV Infections
Intervention: Procedure: Oral swabs for HPV-typing and high-risk HPV-determination
7 Recruiting A Long-term Follow-up of the HIV-NAT Cohort
Condition: HIV Infections
Intervention:
8 Completed Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected Patients
Conditions: HIV Infections;   Malaria
Intervention: Drug: Atovaquone / Proguanil
9 Completed Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevirapine in Patients on Triple Treatment With Analogues Only
Condition: HIV Infections
Intervention: Drug: Nevirapine
10 Active, not recruiting
Has Results
Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children
Condition: HIV Infections
Interventions: Drug: Tenofovir DF;   Drug: Zidovudine;   Drug: Stavudine
11 Completed
Has Results
Metabolic Effects of Switching Kaletra to Boosted Reyataz
Condition: HIV Infections
Interventions: Drug: atazanavir/ritonavir;   Drug: lopinavir/ritonavir
12 Completed A RCT of Prednisone as Adjunctive Therapy for Hospitalized Patients With Pulmonary TB and HIV Co-infection
Conditions: Tuberculosis;   HIV Infections
Interventions: Drug: Prednisone;   Drug: placebo
13 Completed The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: indinavir/ritonavir
14 Terminated BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)
Condition: HIV Infections
Intervention: Drug: Increased dose of Kaletra
15 Completed
Has Results
FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment
Condition: HIV Infections
Interventions: Drug: efavirenz;   Drug: tenofovir;   Drug: emtricitabine
16 Completed
Has Results
Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection
Condition: HIV Infections
Interventions: Drug: Tenofovir disoproxil fumarate/Emtricitabine;   Drug: Lopinavir/Ritonavir
17 Completed Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients
Condition: HIV Infections
Intervention: Drug: Atazanavir
18 Completed TMC125-C203: Phase II Randomized (Patients Are Assigned Different Treatments Based on Chance), Placebo Controlled Dose Escalating Trial of TMC125 in HIV-1 Infected Patients
Conditions: Anti-Retroviral Agents;   HIV-1
Intervention: Drug: TMC125
19 Completed A Trial of Zinc and Micronutrients in Tanzanian Children
Conditions: Diarrheal Illnesses;   Respiratory Illness;   Growth Faltering
Interventions: Drug: Zinc;   Drug: Multivitamins;   Drug: Placebo

Indicates status has not been verified in more than two years